IDIBELL on the media

NO002 - F Fdz Aranda_gens suicidi - Imatge noti

Identified four genes that increase the risk of suicidal thoughts and acts

Although further research is needed to determine whether the identification of genetic markers may lead to the development of new targeted treatments, these findings help to understand how these markers may condition the pathology of suicidal thoughts and actions.

NO005 - Xec Niemann-Pick - Imatge noti

The Niemann-Pick Foundation finances a clinical trial of a drug to stop the cognitive deterioration of the disease

Today the Niemann-Pick Spain Foundation came to deliver the check for 71,056.25 euros that will fully finance a pilot study to determine the efficacy and safety of the drug Efavirenz to alleviate the cognitive deterioration of patients with this minority disease of genetic origin and for which there is currently no treatment. The event was […]

NO001 - V Moreno_Nat Gen - Imatge noti

A study that identifies for the first time more than 100 new genetic factors linked to colorectal cancer

This is the largest study on the genetics of colorectal cancer risk. The study, carried out by a global consortium, with the participation of IDIBELL and the Catalan Institute of Oncology, opens new strategies for treatment and chemoprevention.

Arquitec_MarinaRoca-1

IDIBELL receives 1.2 million euros in grants to promote scientific research and its transfer

Funded projects address different areas of health, from precision radiotherapy to the search for therapies for breast cancer and other diseases.

NO004 - Preaward_Gestores&Redes - Imatge noti

Funded the UPDATE project that will promote the leadership of IDIBELL in Horizon Europe

The Ministry of Science and Innovation and the State Research Agency, in the call for Grants for the Preparation and Management of European Projects, have financed the project “UPDATE – SUPporting IDIBELL reseArchers To succeed in Horizon Europe”.

NP31 - C Muñoz_CDDIS - Imatge noti

A receptor until now considered a death promoter in tumor cells could induce the growth of lung cancer

A study by IDIBELL and the University of Amsterdam published in the journal Cell Death and Disease shows that TRAIL protein receptors induce the expression of IL-8, a protein that promotes tumor development and angiogenesis in lung tumors.

NO112 - BMJ Forocoches - Imatge noti

Does everything cause cancer? Beliefs about cancer among anti-vaxxers and flat earthers: a call to combat misinformation

A team from IDIBELL and the Catalan Institute of Oncology has published the results of a survey that shows that anti-vaccine groups, flat earthers or defenders of the existence of reptilians recognize less the actual cancer causes, and therefore, identify false myths as carcinogens.

NO121 - Esteve_CIBER Imatge noti

Almost 90% of deaths and illnesses in Spain were due to non-infectious diseases such as heart disease, stroke, COPD, Alzheimer’s, and lung cancer

Based on the ‘Global Burden of Disease’ 2019, national researchers led by CIBER, and other Spanish and North American centers, including IDIBELL and ICO, draw a detailed picture of the health in Spain before the pandemic and offer a vision of the future trends.

NO120 - App COVID19 Imatge noti

Researchers develop a model that predicts the COVID-19 clinical evolution at the hospital admission point

A joint project from the UPC, the UB, the HUB, and IDIBELL studied the probability of suffering severe pneumonia, needing ventilation, or even dying during hospital admission due to COVID-19. As a result of the statistical models created, based on data from more than 5,000 patients admitted to five hospitals in different pandemic waves, they developed a web application for the early identification of potentially high-risk COVID-19 patients and the prediction of the disease course.

NP30 - JM Aran_Proj HNA - Imatge noti

hna Foundation collaborates in the development of a new drug against inflammatory bowel diseases

This support will help to develop and characterize a new immunomodulatory compound discovered by the IDIBELL group led by Dr. Josep Maria Aran.

Scroll to Top